• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美容注射剂与射频微针联合使用的安全性:4.5年回顾

Safety of combining cosmetic injectables with radiofrequency microneedling: A 4.5-year review.

作者信息

Wang Jordan V, Valiga Alexander, Albornoz Christian A, Geronemus Roy G

机构信息

Laser & Skin Surgery Center of New York, New York, NY, USA.

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

J Cosmet Dermatol. 2021 Apr;20(4):1084-1085. doi: 10.1111/jocd.13954. Epub 2021 Feb 1.

DOI:10.1111/jocd.13954
PMID:33522699
Abstract

Pairing energy-based treatments, including radiofrequency microneedling, with either injectable neuromodulators or soft-tissue fillers can be an effective therapy for facial rejuvenation. However, there remains concerns by some physicians that this combination may add new risks for adverse events. Theoretical risks of combining energy-based treatment with neuromodulator injections include unintentional spread, which may result in eyelid ptosis and asymmetry. Potential risks with soft-tissue fillers include unexpected loss of filler volume, necrosis, burn, and product migration. In order to shed more light on this topic, we performed a retrospective chart review of single-session facial treatments with radiofrequency microneedling and cosmetic injectables over a 4.5 year period. We found no documented adverse events recorded related to combination treatment. This is important information that adds to the patient safety literature.

摘要

将基于能量的治疗方法,包括射频微针,与可注射神经调节剂或软组织填充剂相结合,可以成为一种有效的面部年轻化治疗方法。然而,一些医生仍然担心这种联合治疗可能会增加不良事件的新风险。基于能量的治疗与神经调节剂注射联合使用的理论风险包括意外扩散,这可能导致上睑下垂和不对称。软组织填充剂的潜在风险包括填充剂体积意外减少、坏死、烧伤和产品迁移。为了更清楚地了解这个问题,我们对4.5年期间采用射频微针和美容注射剂进行的单疗程面部治疗进行了回顾性图表审查。我们没有发现与联合治疗相关的不良事件记录。这是重要的信息,丰富了患者安全方面的文献。

相似文献

1
Safety of combining cosmetic injectables with radiofrequency microneedling: A 4.5-year review.美容注射剂与射频微针联合使用的安全性:4.5年回顾
J Cosmet Dermatol. 2021 Apr;20(4):1084-1085. doi: 10.1111/jocd.13954. Epub 2021 Feb 1.
2
Combining cosmetic injectables with low-energy, low-density 1927 nm fractional thulium fiber laser: A 2.5-year examination on the safety of same-day treatments.将美容注射与低能量、低密度 1927nm 铥光纤激光联合应用:2.5 年同日治疗安全性观察。
J Cosmet Dermatol. 2021 Oct;20(10):3289-3290. doi: 10.1111/jocd.14073. Epub 2021 Mar 25.
3
Exploring facial overfilled syndrome from the perspective of anatomy and the mismatched delivery of fillers.从解剖学和填充物错位分布的角度探讨面部过度饱满综合征。
J Cosmet Dermatol. 2024 Jun;23(6):1964-1968. doi: 10.1111/jocd.16244. Epub 2024 Feb 18.
4
Fillers in dermatology: from past to present.皮肤科中的填充剂:从过去到现在。
Cutis. 2015 Nov;96(5):E17-9.
5
Complications of Injectables.注射剂的并发症。
Atlas Oral Maxillofac Surg Clin North Am. 2024 Mar;32(1):57-63. doi: 10.1016/j.cxom.2023.10.005. Epub 2023 Nov 24.
6
Preinjection aspiration for injectable fillers in aesthetic dermatology: Trust or bust?在美容皮肤科中,注射填充剂前的抽吸:是可信还是不可信?
J Cosmet Dermatol. 2020 May;19(5):1063-1064. doi: 10.1111/jocd.13377. Epub 2020 Mar 17.
7
Male Rejuvenation: Injectables.男性生殖抗衰:注射治疗。
Facial Plast Surg Clin North Am. 2024 Aug;32(3):425-435. doi: 10.1016/j.fsc.2024.02.007. Epub 2024 Mar 28.
8
Minimally Invasive Facial Cosmetic Procedures.微创面部美容手术
Otolaryngol Clin North Am. 2019 Jun;52(3):443-459. doi: 10.1016/j.otc.2019.02.013. Epub 2019 Apr 5.
9
Eyelid and Periorbital Dermal Fillers: Products, Techniques, and Outcomes.眼睑和眶周真皮填充剂:产品、技术和结果。
Facial Plast Surg Clin North Am. 2021 May;29(2):335-348. doi: 10.1016/j.fsc.2021.01.003. Epub 2021 Apr 24.
10
Rheologic properties of soft tissue fillers and implications for clinical use.软组织填充剂的流变学特性及其临床应用意义。
J Cosmet Dermatol. 2021 Jan;20(1):28-34. doi: 10.1111/jocd.13487. Epub 2020 Aug 7.